Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F1U23
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,049
Award facts
- Contract value 100% obligated
- $71,049.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $71,049.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-set-aside award was performed at the contractor's facility in Conshohocken, Pennsylvania. HUMIRA is a biologic immunosuppressant medication commonly prescribed for rheumatoid arthritis, psoriasis, and other autoimmune conditions, making this delivery order consistent with the Defense Health Agency's pharmaceutical supply requirements for military treatment facilities and beneficiaries.
This delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The prime IDC serves as a comprehensive pharmaceutical support vehicle enabling Cencora and its subsidiary AmerisourceBergen Drug Corp to supply a broad range of prescription medications, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor with established federal contracting relationships, AmerisourceBergen regularly fulfills task orders for brand-name and generic medications across multiple therapeutic domains to support the Defense Health Agency and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F1U23?
SPE2DR26F1U23 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F1U23 worth?
The government has obligated $71,049 on SPE2DR26F1U23.
Is contract SPE2DR26F1U23 an order under another contract?
Yes. SPE2DR26F1U23 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U23 competed?
The extent of competition for SPE2DR26F1U23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award